ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,640Medicare Part D Prescriptions Filled, Including Refills

Rank: 175 out of 1111

$588K Total Retail Price of All Prescriptions

Rank: 157 out of 1111

435 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 7,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 442 321 S3 1 1
LEVOTHYROXINE SODIUM 399 344 2 3
SIMVASTATIN 304 277 3 5
OMEPRAZOLE 298 262 4 4
FUROSEMIDE 268 216 5 6
METFORMIN HCL 259 199 6 8
AMLODIPINE BESYLATE 241 193 7 7
METOPROLOL TARTRATE 220 197 8 12
LISINOPRIL 212 183 9 2
TRAMADOL HCL 185 151 10 13
POTASSIUM CHLORIDE 179 167 11 9
WARFARIN SODIUM 159 154 12 19
CITALOPRAM HBR 148 131 13 14
GABAPENTIN 142 105 14 10
CRESTOR 140 109 15 33
MELOXICAM 136 132 16 18
NEXIUM 132 115 17 26
ZOLPIDEM TARTRATE 123 97 18 16
ATORVASTATIN CALCIUM 119 95 19 15
HYDROCHLOROTHIAZIDE 117 115 20 11
ATENOLOL 115 115 21 22
TAMSULOSIN HCL 114 101 22 28
PRAVASTATIN SODIUM 113 102 23 17
CYMBALTA 100 57 24 40
CIPROFLOXACIN HCL 95 77 25 58
LYRICA 89 36 26 62
PLAVIX 84 74 27 49
DONEPEZIL HCL 84 84 27 25
CLOPIDOGREL 81 68 29 30
METOPROLOL SUCCINATE 75 58 30 20
CARVEDILOL 69 69 31 21
FLUOXETINE HCL 68 40 32 44
LOSARTAN-HYDROCHLOROTHIAZIDE 62 46 33 72
ISOSORBIDE MONONITRATE ER 62 56 33 73
LOSARTAN POTASSIUM 61 56 35 34
LEVOFLOXACIN 59 46 36 88
GEMFIBROZIL 59 35 36 92
PAROXETINE HCL 53 28 38 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 53 38 23
SERTRALINE HCL 52 40 40 24
TRAZODONE HCL 50 32 41 32
NAMENDA 50 49 41 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.